Jonathan Slonin sold $71K of PCRX stock

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, Inc. (PCRX), sold 3,040 shares of PCRX stock worth $71K, per an SEC Form 4 filed Aug 18, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 17, 2026, 1 day before it was made public.

PCRX has moved +56.9% since the trade date, from $23.24 to $36.46 (Nov 12, 2026 close).